Article Details
Retrieved on: 2021-06-22 13:45:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
EMA's committee for human medicines (CHMP) has approved additional manufacturing sites for the production of Comirnaty, the COVID-19 vaccine ...
Article found on: www.ema.europa.eu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here